Effect of Ketamine on Postoperative Clinical Outcomes



Status:Enrolling by invitation
Conditions:Colorectal Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 80
Updated:4/17/2018
Start Date:May 2011
End Date:October 2020

Use our guide to learn which trials are right for you!

Intraoperative Ketamine Administration in Colorectal Surgery: Effect on Postoperative Clinical Outcomes

The purpose of this research is to evaluate the effectiveness of ketamine as an analgesic
adjuvant in decreasing the narcotic (opioids) analgesics during surgery, on pain management
and on the later recovery after surgery in patients undergoing colorectal surgery.

Adjuvant is a drug that has few or no pharmacological effects by itself, but may increase the
effectiveness or strength of other drugs when given at the same time.

Inclusion Criteria

1. Patients scheduled to undergo small and/or large partial bowel resection via
laparotomy or laparoscopy

2. Willingness and ability to sign an informed consent document

3. No allergies to anesthetic or analgesic medications

4. 18 - 80 years of age

5. American Society of Anesthesiologists (ASA) Class I - III adults of either sex

Exclusion Criteria

1. Inability to comprehend the pain assessment tools

2. Patients with known allergy, hypersensitivity or contraindications to anesthetic or
analgesic medications

3. Patients with clinically-significant heart disease including arrhythmias and
significant hypertension, brain aneurysms, prior history of cerebral vascular accident
(CVA), or chronic renal insufficiency

4. Prior abdominal surgery

5. History of abdominal carcinomatosis

6. History of radiation enteritis;

7. Patients with history of hepatic, renal, cardiac failure, organ transplant, or
diabetes

8. Patients with seizures

9. Morbid obesity (body mass index >40)

10. Pregnant or lactating women

11. Subjects with a history of alcohol or drug abuse within the past 3 months

12. Any other conditions or use of any medication which may interfere with the conduct of
the study

13. Prophylactic Nasogastric Tube (NGT) use

14. Individuals with significant manic disorders including: schizophrenia, or bipolar
disorder or psychosis

15. Individuals with asthma and/or thyroid diseases
We found this trial at
1
site
8700 Beverly Blvd # 8211
Los Angeles, California 90048
(1-800-233-2771)
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials